Catheter-Related Infections
0
Pipeline Programs
6
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Baxter InternationalDEERFIELD, IL
1 programComparison of Infection Rates Among Patients Using Two Catheter Access DevicesN/A1 trial
Active Trials
BaxterCosta Rica - Cartago
1 programComparison of Infection Rates Among Patients Using Two Catheter Access DevicesN/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Syneos HealthLocking Solution
Baxter InternationalComparison of Infection Rates Among Patients Using Two Catheter Access Devices
Clinical Trials (2)
Total enrollment: 10,017 patients across 2 trials
DuraLock-C Catheter Lock Solution
Start: Sep 2021Est. completion: Jun 202317 patients
N/ATerminated
NCT00965198Baxter InternationalComparison of Infection Rates Among Patients Using Two Catheter Access Devices
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
Start: Nov 2009Est. completion: Jul 201110,000 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
6 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.